Biotechnology in oral care

Biotechnology in Personal Care

Volumn , Issue , 2016, Pages 323-352

  Cummins, Diane ^a   Bowen, William H ^b  

^a Oral Care Research and Development   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885918127     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (103)

1. NCHS-Healthy People 2000. Oral Health Progress Review. National Center for Chronic Disease Prevention and Health Promotion. Available online at www.cdc.gov/OralHealth/factsheets/sgr2000-fsl.htm.
2. Brown LJ, Loe H. Prevalence, extent, severity and progression of periodontal disease. Periodontol 2000 1993; 27(2):57-71.
3. Axelsson P, Lindhe J. Effect of controlled oral procedures on caries and periodontal disease in adults. J Clin Periodontol 1990; 17:729-733.
4. Albandar JM, Brunell JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999; 70:13-29.
5. Pitts NB. Clinical diagnosis of dental caries: a European perspective. J Dent Educ 2001; 65:972-978.
6. Dove SB. Radiographic diagnosis of dental caries. J Dent Educ 2001; 65:985-990.
7. Stookey GK, Gonzalez-Cabezas C. Emerging methods of caries diagnosis. J Dent Educ 2001; 65:1001-1006.
8. Tanzer JM, Livingston J, Thomson A. The microbiology of primary dental caries in humans. J Dent Educ 2001; 65:1029-1037.
9. Saxton CA, van der Ouderaa FJG. The effect of a dentifrice containing zinc citrate and triclosan on developing gingivitis. J Periodontol Res 1989; 24:75-80.
10. Rosling B, Wannfors B, Volpe AR, Furuichi Y, Ramberg P, Lindhe J. The use of a triclosan/copolymer dentifrice may retard the progression of periodontitis. J Clin Periodontol 1997; 24:873-880.
11. Socransky SS, Haffajee AD, Cugini MA. Microbial complexes in subginvigal plaque. J Clin Periodontol 1998; 25:134-144.
12. Page RC, Offenbacher S, Schroeder HE. Advances in the pathogenesis of periodontitis:summary of developments, clinical implications and future directions. Periodontol 2000 1997; 14:216-248.
13. Costerton JW, Lewandowski Z, DeBeer D, Caldwell D, Korber D, James G. Biofilms, the customized microniche. J Bacteriol 1994; 176(8):2137-2142.
14. Marsh PD. Dental plaque as a microbial biofilm. Caries Res 2004; 38:204-211.
15. Paster BJ, Boches SK, Galvin JL. Bacterial diversity in human subgingivial plaque. J Bacteriol 2001; 183:3770-3783.
16. Critchley P, Wood JM, Saxton CA, Leach SA. The polymerization of dietary sugars by dental plaque. Caries Res 1967; 1:112-129.
17. Bowen WH, Velez H, Aquila M, Velasquez H, Sierra LI, Gillespie G. The microbiology and biochemistry of plaque, saliva and drinking water from two communities with contrasting levels of caries in Columbia, SA. J Dent Res 1977; 56:C32-C39.
18. Hotz P, Guggenheim B, Schmid R. Carbohydrates in pooled dental plaque. Caries Res 1972; 6:103-121.
19. Vacca-Smith AM, Bowen WH. In situ studies of pellicle formation on hydroxyapatite discs. Arch Oral Biol 2000; 45:277-291.
20. Al-Hashimi I, Levine MJ. Characterization of in vivo saliva-derived enamel pellicle. Arch Oral Biol 1989; 34:289-295.
21. Schilling KM, Blitzer MH, Bowen WH. Adherence of Streptococcus mutans to glucans formed in situ in salivary pellicle. J Dent Res 1989; 68:1678-1680.
22. Clark WB, Bammann LL, Gibbons RJ. Comparative estimated bacterial affinities and adsorption sites on hydroxyapatite surfaces. Infect Immun 1978; 19:846-853.
23. Busscher HJ, van der Mei JC. Physico-chemical interactions in initial microbial adhesion and relevance for biofilm formation. Adv Dent Res 1997; 11(1):24-32.
24. Jenkinson HF, Lamont RJ. Streptococcal adhesion and colonization. Crit Rev Oral Biol Med 1997; 8:175-200.
25. Kolenbrander PE. Oral microbial communities: biofilms, interactions, and genetic systems. Ann Rev Microbiol 2000; 54:413-437.
26. Vacca-Smith A, Bowen WH. Binding properties of streptococcal glucosyltransferases for hydroxyapatite and bacterial surfaces. Arch Oral Biol 1998; 43:103-110.
27. McCabe RM, Denkerstoat JA. Adherence of Veillonella species mediated by extracellular glucosyltransferase from Streptococcus salivarius. Infect Immun 1977; 18:726-734.
28. Yamashita Y, Bowen W, Burne RA, Kuramitsu H. Role of Streptococcus mutans glucosyltransferase genes in caries induction in the specific-pathogen-free rat model. Infect Immun 1993; 61:3811-3817.
29. Listgarten M. Formation of dental plaque and other biofilms. In: Newman HN, Wilson M, eds. Dental Plaque Revisited: Oral Biofilms in Health and Disease. Cardiff: Biocure 1999:187-210.
30. Auschill TM, Arweiler NB, Natuschel L, Brecx M, Reich E, Sculean A. Spatial distribution of vital and dead organisms in dental biofilms. Arch Oral Biol 2001; 46:471-476.
31. Bowen WH. Food components and caries. Adv Dent Res 1994; 8:215-220.
32. Geddes DAM. Acids produced by human dental plaque metabolism in situ. Caries Res 1975; 9:98-109.
33. Quivey RG, Kuhnert WL, Hahn K. Adaptation of oral streptococci to low pH. Adv Micro Physiol 2000; 42:239-274.
34. Sturr MG, Marquis RE. Inhibition of proton-translocating ATPases of Streptococcus mutans and Lactobacillus casei by fluoride and aluminum. Arch Microbiol 1990; 155:22-27.
35. Bender GR, Sutton SV, Marquis RF. Acid tolerance, proton permeabilities and membrane ATPases of oral streptococci. Infect Immun 1986; 53:331-338.
36. Marquis R, Bender GR, Murray DR, Wong A. Arginine deiminase system and bacterial adaptation to acid environments. Appl Environ Microbial 1987; 53: 198-200.
37. Meyerowitz C. Caries in renal dialysis patients. In: Bowen WH, Tabak LA, eds. Cariology for the Nineties. Rochester, NY: University of Rochester Press, 1993: 249-260.
38. Stickland LH. Studies on the metabolism of the strict anaerobes (Genus Clostridium). I. The chemical reactions by which Cl. sporogenes obtains its energy. Biochem J 1934; 28:1746-1759.
39. Curtis M, Eastoe J. Comparison of free amino acid pools in dental plaque fluid from monkeys (Macaca fascicularis) fed on high and low sugar diets. Arch Oral Biol 1978; 23:989-992.
40. Haffajee AD, Socransky SS. Microbial etiologic agents of destructive periodontal diseases. Periodontology 2000 1994; 5:78-111.
41. Listgarten M. The structure of dental plaque. Periodontology 2000 1994; 5:52-62.
42. Darveau R, Tanner A. The microbial challenge in periodontitis. Periodontology 2000 1997; 14:24-32.
43. Page RC. The etiology and pathogenesis of periodontitis. Compendium 2002; 23(suppl 5):11-14.
44. Scannapieco FA. Periodontal inflammation: from gingivitis to systemic disease? Compend Contin Educ Dent 2004; 25(7 suppl 1):16-25.
45. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol 1998; 3:51-61.
46. van der Ouderaa FJG, Cummins D. Delivery systems for supra- and sub-gingival plaque control. J Dent Res 1989; 68:1617-1624.
47. Newman HN. The rationale for chemical adjuncts in plaque control. Int Dent J 1998; 48(suppl 1):298-304.
48. Cummins D. Mechanisms of action of clinically proven antiplaque agents. In:Embery G, Rolla G, eds. Clinical and Biological Aspects of Dentifrices. Oxford:Oxford University Press, 1992:205-228.
49. 21 CFR 355; Anti-caries Drug Products for Over-the-Counter Human Use; www. accessdata.fda.gov/scripts/cdrh/cfdocs/cf CFR/CFR search.cfm?CFRpatr_355 sources 60FR52507, Oa 1995.
50. Lynch RJM, Navada K, Walia R. Low levels of fluoride in plaque and saliva and their effects on de-mineralization and re-mineralization of enamel. Int Dent J 2004; 5:310-314.
51. Sutton SV, Bender GR, Marquis RE. Fluoride inhibition of proton-translocating ATPases of oral bacteria. Infect Immun 1987; 55:2597-2603.
52. Marquis RF. Antimicrobial actions of fluoride for oral bacteria. Can J Microbiol 1995; 41:955-964.
53. Bowen WH, Hewitt MJ. Effect of fluoride on extracellular polysaccharide production by Streptococcus mutans. J Dent Res 1974; 53:331-338.
54. Edgar WM, Ingram GS, Morgan SN. Fluoride in saliva and plaque in relation to fluoride in drinking water and in dentifrice. In: Embery G, Rolla G, eds. Clinical and Biological Aspects of Dentifrices. Oxford University Press, 1992:145-156.
55. Scheie AA. Dentifries in the control of dental caries. In: Embery G, Rolla G, eds. Clinical and Biological Aspects of Dentifrices. Oxford University Press, 1992:29-40.
56. Mirth D, Adderly DD, Amsbaugh SM, Monell-Torrens E, Li SH, Bowen WH. Inhibition of experimental dental caries using an intraoral fluoride-releasing device. J Am Dent Assoc 1983; 107:55-58.
57. Meyerowitz C, Watson GE. The efficacy of an intraoral fluoride-releasing system in irradiated head and neck cancer patients; a preliminary study. J Am Dent Assoc 1998; 129:1252-1259.
58. Moran J, Addy M, Newcombe R. Comparison of the effect of toothpastes containing enzymes or antimicrobial compounds with a conventional fluoride toothpaste on the development of plaque and gingivitis. J Clin Periodontol 1989; 16:295-299.
59. Inoue M, Yakushiji T, Mizuno T, Yamamoto J, Tanii S. Inhibition of dental plaque formation by mouthwash containing an endo-alpha-1,3 glucanase. Clin Prev Dent 1990; 12:10-14.
60. Fitzgerald RJ, Spinell DM, Stoudt TH. Enzymatic removal of artificial plaques. Arch Oral Biol 1968; 13:125-128.
61. Goldstein-Lifschitz B, Bauer S. Comparison of dextranases for their possible use in eliminating dental plaque. J Dent Res 1976; 55(5):886-892.
62. Bowen WH. The effect of dextranase on caries activity in monkeys (Macaca inus). Br Dent J 1971; 131:445-449.
63. Guggenheim B, Regolati B, Schmid R, Meeklemann R. Effects of the topical application of mutanase on rat caries. Caries Res 1980; 14:128-135.
64. Caldwell RC, Sandham HJ, Mann WV Jr, Finn SB, Formicola AJ. 1. The effect of a dextranase mouthwash on dental plaque in young adults and children. J Am Dent Assoc 1971; 82:124-131.
65. Lobene RR. 2. A clinical study of the effect of dextranase on human dental plaque. J Am Dent Assoc 1971; 82:132-135.
66. Keyes PH, Hicks MA, Goldman BM, McCabe RM, Fitzgerald RJ. 3. Dispersion of dextranous bacterial plaques on human teeth with dextranase. J Am Dent Assoc 1971; 82:136-141.
67. Budtz-Jörgensen E. Prevention of denture plaque formation by an enzyme denture cleanser. J Biol Buccale 1977; 5:239-244.
68. Bowen WH. Unpublished data, 2005.
69. Schilling KM, Blitzer MH, Bowen WH. Adherence of Streptococcus mutans to glucans formed in situ in salivary pellicle. J Dent Res 1989; 68:1678-1680.
70. Marotta M, Martino A, De Rosa A, Farina E, Carteni M, De Rosa M. Degradation of dental plaque glucans and prevention of glucan formation using commercial enzymes. Process Biochem 2002; 38:101-108.
71. Barker SA, Giblin AG, Gray CJ, Bowen WH. Preparation and properties of a conjugate containing dextranase and concanavalin A. Carbohyd Res 1974; 36:23-33.
72. Lenander-Lumikari M, Tenovuo J, Mikola H. Effects of a lactoperoxidase systemcontaining toothpaste on levels of hypothiocyanite and bacteria in saliva. Caries Res 1993; 27:285-291.
73. Modesto A, Lima KC, de Uzeda M. Effects of three different infant dentifrices on biofilms and oral microorganisms. J Clin Pediatr Dent 2000; 24(3):237-243.
74. Addy M. Chlorhexidine compared to other locally delivered antimicrobials. J Clin Periodontol 1986; 13:957-964.
75. Duffner F, Bertoldo C, Andersen JT, Wagner K, Antranikian G. A new thermoactive pullulanase from Desulfurococcus mucosus: cloning, sequencing, purification, and characterization of the recombinant enzyme after expression in bacillus subtilis. J Bacteriol 2000; 182(22):6331-6338.
76. Kulminskaya AA, Thomsen KK, Shabalin KA, Sidorenko IA, Eneyskaya EV, Savel'ev AN, Neustroev KN. Isolation, enzymatic properties, and mode of action of an exo-1,3-b-glucanase from Trichoderma viride. Eur J Biochem 2001; 268:6123-6131.
77. Hahn Berg IC, Kalfas S, Malmsten M, Arnebrant T. Proteolytic degradation of oral biofilms in vitro and in vivo: potential of proteases originating from Euphausia superba for plaque control. Eur J Oral Sci 2001; 109:316-324.
78. Ryu SJ, Kim D, Ryu HJ, Chiba S, Kimura A, Day DF. Purification and partial characterization of a novel glucanhydrolase from Lipomyces starkeyi KSM 22 and its use of inhibition of insoluble glucan formation. Biosci Biotechnol Biochem 2000; 64(2):223-228.
79. Kim D, Ryu SJ, Heo SJ, Kim DW, Kim HS. Characterization of a novel carbohydrase from Lipomyces starkeyi KSM 22 for dental applications. J Microbiol Biotechnol 1999; 9:260-264.
80. Johansen C, Falholt P, Gram L. Enzymatic removal and disinfection of bacterial biofilms. Appl Environ Microbio 1997; 63(9):3724-3728.
81. Taubman MA, Smith DJ. Vaccination: a cariostatic option? In: Bowen WH, Tabak LA, eds. Cariology for the Nineties. Rochester, NY: University of Rochester Press, 1993:441-457.
82. Bowen WH. Relevance of caries vaccine investigations in rodents, primates and human: critical assessment. In: Bowen WH, Genco RJ, O'Brien TC, eds. Immunologic Aspects of Dental Caries. Spec. Suppl., Immunol. Abstr. Washington DC:Information Retrieval Inc., 1976:11-20.
83. Bowen WH. Vaccine against dental caries-a personal view. J Dent Res 1996; 75:1530-1533.
84. Kelly CG, Medaglini D, Younson JS, Pozzi G. Biotechnological approaches to fight pathogens at mucosal sites. Biotechnol Gene Eng Rev 2001; 18:329-347.
85. Winter G. Synthetic human antibodies and a strategy for protein engineering. FEBS Lett 1998; 30:92-94.
86. Larrick JW, Yu L, Chen J, Jaiswal S, Wycoff K. Production of antibodies in transgenic plants. Res Immunol 1998; 149(6):603-608.
87. Ma JK, Lehner T, Stabila P, Fax CT, Hiatt A. Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. Eur J Immunol 1994; 24:131-138.
88. Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB, Lehner T. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 1998; 4(5):601-606.
89. Weintraub JA, Hilton FF, White JM, Hoover CL, Wycoff K, Wu L, Larrick J, Featherstone JDB. A plant derived mutans streptococci antibody clinical trial. Caries Res. In press, 2005.
90. Bowen WH, Schilling K, Giertsen E, Pearson S, Lee SF, Bleiweis A, Beeman D. Role of a cell surface-associated protein in adherence and dental caries. Infect Immun 1991; 59:4606-4609.
91. Shimazakik Y, Mitoma M, Oho T, Nakano Y, Yamashita Y, Okano K, Nakano Y, Fukuyana M, Fijihara N, Nada Y, Koga T. Passive immunization with milk produced from an immunized cow prevents oral recolonization by Streptococcus mutans. Clin Diagn Lab Immunol 2001; 8:1136-1139.
92. Mitoma M, Oho T, Michibata N, Okano K, Nakano Y, Fukyuwama M, Koga T. Passive immunization with bovine milk containing antibodies to a cell surface protein antigen-glucosyltransferase fusion protein protects rats against dental caries. Infect Immun 2002; 70:2721-2724.
93. Kruger C, Pearson SK, Kodama Y, Vacca-Smith A, Bowen WH, Hamanstrom L. The effects of egg-derived antibodies to glucosyltransferases on dental caries in rats. Caries Res 2004; 38:9-14.
94. Booth V, Ashley FP, Lehner T. Passive immunization with monoclonal antibodies against Porphyromonas gingivitis in patients with periodontitis. Infect Immun 1996; 64:422-427.
95. Abiko Y. Passive immunization against dental caries and periodontal disease:development of recombinant and human monoclonal antibodies. Crit Rev Oral Biol Med 2000; 11(2):140-158.
96. Hillman JD, Socransky SS. Replacement therapy of the prevention of dental disease. Adv Dent Res 1987; 1:119-125.
97. Hillman JD, Principles of microbial ecology and their application to xerostomiaassociated opportunistic infections of the oral cavity. Adv Dent Res 1996; 10(1):66-68.
98. Tagg JR, Dierksen KP. Bacterial replacement therapy: adapting "germ warfare" to infection prevention. Trends Biotechnol 2003; 21(5):217-223.
99. BLIS K12 Throat guard lozenges markted by BLIS Technologies Limited, Wellington, New Zealand. Access: www.blis.co.nz.
100. de Vos WM, Hugenholtz J. Engineering metabolic highways in Lactocci and other lactic acid bacteria. Trends Biotechnol 2004; 22(2):72-79.
101. Marshall RI. Gingival defensins: linking the innate and adaptive immune responses to dental plaque. Periodontol 2000, 2004; 35:14-20.
102. Kuepper MB, Huhn M, Spiegel H, Ma J, Barth S, Fischer R, Finnern R. Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approach. BMC Biotechnol 2005; 5:4.
103. Clancy K, Pearson S, Bowen WH, Burne RA. Characteriation of recombinant urealytic Streptococcus mutans demonstrates an inverse relationship between dental plaque, urealytic capacity, and cariogenicity. Infect Immun 2000; 68:2621-2629.